Global Health News Highlights: From Bird Flu to Vaccination Debates
Current health news covers Brazilian chicken restrictions due to bird flu, Nestle's phasing out of synthetic colors in the US, Novo Nordisk launching Wegovy in India, and controversies over US CDC vaccine presentations. The U.S. plans to stop funding Gavi, and legal challenges face CVS over illegal practices.
In a series of health news briefs, the Brazilian Agriculture Ministry updated its list of countries that have placed restrictions on chicken trade following the confirmation of bird flu on a commercial farm. The ministry is optimistic about reversing these bans soon.
Nestle USA announced plans to eliminate synthetic food colors from its portfolio by mid-2026, with more than 90% of its current products already synthetic-free. Meanwhile, Novo Nordisk launched its weight-loss drug Wegovy in India, marking another battlefront with Eli Lilly's Mounjaro.
In the realm of vaccines, questions arose as the US CDC's vaccine presentation cited a non-existent study, causing a stir. Meanwhile, the U.S. government announced the cessation of funding to Gavi, a global vaccine alliance, amidst criticism of its safety protocols.
(With inputs from agencies.)
- READ MORE ON:
- health
- bird flu
- Brazil
- synthetic colors
- Nestle
- weight-loss drug
- Wegovy
- vaccines
- Gavi
- Vaccine Alliance
ALSO READ
Novo Nordisk Advances Revolutionary Weight-Loss Drug to Late-Stage Trials
Health Headlines: Weight-Loss Drug Updates, Insurance Changes, and Vape Smuggling
Novo Nordisk's Weight-loss Drug Trial and Eli Lilly's Promising Obesity Treatment
High Retention on Weight-Loss Drugs Wegovy and Zepbound as Coverage Expands
Nestle India Announces 1:1 Bonus Shares, First Since 1996
Google News